Pro-inflammatory effect of fibrinogen and FDP on vascular smooth muscle cells by IL-6, TNF-α and iNOS
Pro-inflammatory effect of fibrinogen and FDP on vascular smooth muscle cells by IL-6, TNF-α and iNOS
复制标题
DOI:
10.1016/j.lfs.2011.03.003
复制
发表时间:
2011-05-09
期刊:
影响因子:
6.1
通讯作者:
Pang, Xiaoming
中科院分区:
文献类型:
--
作者:
Lu, Pei-pei;Liu, Jun-tian;Pang, Xiaoming
Aims: Atherosclerosis is a chronic inflammatory response of the arterial wall to multiple endothelial injuries. As one of the inflammatory markers, fibrinogen has been implicated in pathogenesis of atherosclerosis. But, it is not completely understood whether atherogenesis of fibrinogen is related to its pro-inflammatory effect on vascular smooth muscle cells (VSMCs). The purpose of the present study was to observe effects of fibrinogen and fibrin degradation products (FDP) on interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-alpha), and inducible nitric oxide synthase (iNOS) generation in rat VSMCs.Main methods: Rat VSMCs were cultured, and fibrinogen and FDP were used as stimulants for IL-6, TNF-alpha, and iNOS. IL-6 and TNF-alpha level in the supernatant were measured by ELISA, mRNA expression of IL-6, TNF-alpha, and iNOS were assayed with RT-PCR, and protein expression of iNOS was detected with western blot and immunocytochemistry.Key findings: Fibrinogen and FOP both significantly stimulated mRNA and protein expressions of IL-6. TNF-alpha and iNOS in VSMCs in time- and concentration-dependent ways. The pro-inflammatory potency of FOP is higher than fibrinogen, which seems to mean that smaller fragments of the protein have greater proinflammatory activity. Fibrinogen and FDP promote more protein expressions of IL-6 and TNF-alpha compared to iNOS, suggesting that fibrinogen and FOP produce a pro-inflammatory effect on VSMCs mainly by IL-6 and TNF-alpha.Significance: These findings are helpful to better understand pro-inflammatory effect of fibrinogen on VSMCs involved in atherogenesis, and imply a therapeutic strategy targeting hyperfibrinogenemia in atherosclerosis. (C) 2011 Elsevier Inc. All rights reserved.